Less Ads, More Data, More Tools Register for FREE

Pin to quick picksClose Bros Regulatory News (CBG)

Share Price Information for Close Bros (CBG)

Share Price is delayed by 15 minutes
Get Live Data
458.60    1.40 (0.31%)
Bid:
457.20
Ask:
458.80
Spread: 1.60 (0.35%)
Market Cap: £691.12m
CBG Live PriceLast checked at - London Stock Exchange

Intraday Close Bros Share Chart

Further update in relation to Motor Commissions

14 Oct 2025 07:00

RNS Number : 1928D
Close Brothers Group PLC
14 October 2025
 

This announcement contains inside information

Further update in relation to motor finance commissions

14 October 2025

Following the publication of the Financial Conduct Authority ("FCA")'s consultation paper on 7 October 2025 on a proposed industry-wide redress scheme in respect of motor finance commissions, Close Brothers Group plc ("the group") has carried out a review of the potential financial impact of the proposed scheme.

The group's existing provision of £165.0 million was based on a range of probability-weighted redress scenarios. The FCA consultation provides more detail on the proposed redress scheme, including the commission models that would be in scope, how unfairness would be assessed, and the proposed approach to calculation of redress. The proposals indicate that the potential financial impact would sit towards the higher end of the group's previous scenarios.

While uncertainty in relation to the outcome of the consultation remains, the group has updated its range of probability-weighted scenarios resulting in an additional expected charge of around £135 million, increasing the total provision to approximately £300 million. This reflects a greater likelihood that more historical cases, particularly those involving Discretionary Commission Arrangements, would qualify for redress, as well as the possibility of the proposed redress methodology resulting in higher compensation levels than reflected in some of the group's previous range of scenarios.

The group is committed to achieving a fair outcome for customers and providing redress where loss has occurred. However, it does not believe the redress methodology proposed by the FCA appropriately reflects actual customer loss or achieves a proportionate outcome. In addition, the FCA's proposed approach to assessing unfairness does not align with the legal clarity provided by the Supreme Court judgement in respect of the "Johnson" case, which confirmed that the test for unfairness is highly fact specific and must take into account a broad range of factors. The group will continue to engage with the FCA in respect of these points.

The total c.£300 million provision, which includes both redress and certain operational costs, represents the group's current best estimate based on all available information at this stage. The ultimate cost to the group could be materially higher or lower than the estimated provision depending on the outcome of the consultation and any further legal, regulatory or industry developments.

The group remains confident in its capital strength, with a Common Equity Tier 1 ("CET1") ratio of 13.8% (14.3% reflecting the disposal of Winterflood1) as at 31 July 2025. The additional provision is expected to reduce the CET1 capital ratio by approximately 130 basis points on a pro-forma basis as at 31 July 20252. Taking into account the estimated CET1 benefit from the sale of Winterflood of c.55 basis points alongside the impact of the estimated provision, the pro-forma CET1 capital ratio would be c.13.0%, significantly above the group's regulatory requirement of 9.7%.

 

 

 

Footnotes

1 Reflecting the estimated CET1 benefit from the sale of Winterflood. The announced sale of Winterflood is expected to increase the group's CET1 capital ratio by c.55 basis points on a pro-forma basis as at 31 July 2025, of which c.30 basis points will be recognised upon completion, with a further c.25 basis points expected in due course from the reduction in operational risk weighted assets.

2 The estimated financial impact included in this announcement is unaudited and remains subject to review as part of the group's interim and full-year audit processes.

Inside information

This announcement contains information which is deemed by the Company to constitute inside information within the meaning of the UK version of the European Union's Market Abuse Regulation ((EU) No. 596/2014). Upon the publication of this announcement via the Regulatory Information Service, the inside information is now considered to be in the public domain. The person responsible for arranging the release of this information on behalf of the Company is Sarah Peazer-Davies, Group General Counsel and Company Secretary.

Enquiries

Camila Sugimura Close Brothers Group plc 020 3857 6577

Sam Cartwright H/Advisors Maitland 07827 254561

 

About Close Brothers

Close Brothers is a UK specialist banking group providing lending, deposit taking and securities trading. We employ approximately 3,000 people, principally in the United Kingdom and Ireland. Close Brothers Group plc is listed on the London Stock Exchange and is a constituent of the FTSE 250.

Cautionary Statement

Certain statements included or incorporated by reference within this announcement may constitute "forward-looking statements" in respect of the group's operations, performance, prospects and/or financial condition. All statements other than statements of historical fact are, or may be deemed to be, forward-looking statements. Forward-looking statements are sometimes, but not always, identified by their use of a date in the future or such words as "anticipates", "aims", "due", "could", "may", "will", "should", "expects", "believes", "intends", "plans", "potential", "targets", "goal" or "estimates". By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions and actual results or events may differ materially from those expressed or implied by those statements. There are also a number of factors that could cause actual future operations, performance, financial conditions, results or developments to differ materially from the plans, goals and expectations expressed or implied by these forward-looking statements and forecasts. These factors include, but are not limited to, those contained in the group's annual report (available at: https://www.closebrothers.com/investor-relations). Accordingly, no assurance can be given that any particular expectation will be met and reliance should not be placed on any forward-looking statement. Additionally, forward-looking statements regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future.

Except as may be required by law or regulation, no responsibility or obligation is accepted to update or revise any forward-looking statement resulting from new information, future events or otherwise. Nothing in this announcement should be construed as a profit forecast. Past performance cannot be relied upon as a guide to future performance and persons needing advice should consult an independent financial adviser.

This announcement does not constitute or form part of any offer or invitation to sell, or any solicitation of any offer to subscribe for or purchase any shares or other securities in the company or any of its group members, nor shall it or any part of it or the fact of its distribution form the basis of, or be relied on in connection with, any contract or commitment or investment decisions relating thereto, nor does it constitute a recommendation regarding the shares or other securities of the company or any of its group members. Statements in this announcement reflect the knowledge and information available at the time of its preparation. Liability arising from anything in this announcement shall be governed by English law. Nothing in this announcement shall exclude any liability under applicable laws that cannot be excluded in accordance with such laws.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FURDBBDGBGBDGUX
Date   Source Headline
1st Jun 20264:15 pmRNSTotal Voting Rights
21st May 20265:15 pmRNSDirector/PDMR Shareholding
21st May 20267:00 amRNSTrading Statement
13th May 20261:00 pmRNSRedemption of Subordinated Notes due 2031
6th May 20264:00 pmRNSDirector/PDMR Shareholding
1st May 20263:00 pmRNSTotal Voting Rights
29th Apr 202612:15 pmRNSDirector/PDMR Shareholding
23rd Apr 202611:45 amRNSHolding(s) in Company
15th Apr 20265:45 pmRNSHolding(s) in Company
14th Apr 20265:00 pmRNSDirector/PDMR Shareholding
9th Apr 20265:15 pmRNSDirector/PDMR Shareholding
8th Apr 20264:46 pmRNSDirector/PDMR Shareholding
8th Apr 20267:00 amRNSUpdate in relation to motor finance commissions
1st Apr 20264:15 pmRNSTotal Voting Rights
30th Mar 20265:08 pmRNSStatement in relation to motor finance commissions
17th Mar 20264:30 pmRNSTransaction in Own Shares
17th Mar 20267:00 amRNSHalf-year Report for six months to 31 January 2026
17th Mar 20267:00 amRNSHalf-year Report for six months to 31 January 2026
16th Mar 20265:40 pmRNSStatement regarding report from Viceroy Research
6th Mar 20264:45 pmRNSDirector/PDMR Shareholding
2nd Mar 20265:45 pmRNSTotal Voting Rights
23rd Feb 20264:45 pmRNSTransaction in Own Shares
16th Feb 20264:30 pmRNSTransaction in Own Shares
9th Feb 20265:45 pmRNSDirector/PDMR Shareholding
9th Feb 20265:30 pmRNSTransaction in Own Shares
3rd Feb 20269:40 amRNSResult of Tender Offer
2nd Feb 20265:25 pmRNSTransaction in Own Shares
2nd Feb 20265:10 pmRNSTotal Voting Rights
30th Jan 20263:00 pmRNSPublication of Admission Particulars
26th Jan 20265:00 pmRNSTransaction in Own Shares
26th Jan 20269:20 amRNSTender Offer
19th Jan 20265:30 pmRNSTransaction in Own Shares
12th Jan 20265:45 pmRNSDirector/PDMR Shareholding
12th Jan 20263:45 pmRNSTransaction in Own Shares
7th Jan 20265:45 pmRNSTransaction in Own Shares
6th Jan 20265:15 pmRNSDirector/PDMR Shareholding
5th Jan 20262:45 pmRNSTotal Voting Rights
29th Dec 20254:40 pmRNSDirector/PDMR Shareholding
29th Dec 20254:40 pmRNSDirector/PDMR Shareholding
22nd Dec 20253:30 pmRNSTransaction in Own Shares
22nd Dec 20253:30 pmRNSTransaction in Own Shares
15th Dec 20254:00 pmRNSHolding(s) in Company
15th Dec 202512:02 pmRNSTransaction in Own Shares
8th Dec 20255:15 pmRNSDirector/PDMR Shareholding
2nd Dec 20254:30 pmRNSTotal Voting Rights
1st Dec 20257:00 amRNSClose Brothers completes Winterflood sale to Marex
28th Nov 20254:45 pmRNSDirector/PDMR Shareholding
24th Nov 20255:00 pmRNSTransaction in Own Shares
20th Nov 20252:34 pmRNSResult of AGM
20th Nov 20257:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.